Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > How long to BTD and then AA

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Apr 28, 2023 8:26am

119 Views

Post# 35418742

RE:RE:RE:RE:RE:RE:RE:How long to BTD and then AA

I believe they have more than enough patients for BTD. They can and will have to show All data, both with and without 16 non eligible patients. (12 undertreated, 1 who died and 3 from PH1). The FDA will be able to evaluate the effect of these undertreated and non eligible patients on the overall data. I expect guidance on AA after data submitted. Just IMHO

<< Previous

Bullboard Posts

Next >>

BMO launches enhanced platform with tools for options trading